{"disease":{"id":"epidermal-growth-factor-receptor-egfr-protein-overexpression","name":"epidermal growth factor receptor egfr protein overexpression"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02205047","title":"Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}